RECRUITING

Functional Assessment in Liver Transplantation

Talk to us

Conditions

End Stage Liver DiseaseCirrhosisLiverLiver TransplantFrailtyend stage

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of frailty, functional status, and disability using functional status measures at baseline and at every clinic visit in the pre-transplant setting. Subjects will also answer questions regarding quality of life, personality, and/or cognitive function. Subjects will again undergo assessments at every clinic visit through 12 months after transplant. Then, they will be followed annually.

Official Title

Functional Assessment in Liver Transplant Candidates (FrAILT) Study

Quick Facts

Study Start:2011-10-12
Study Completion:2028-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03228290

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult (≥18 years old)
  2. * Are seen for the treatment of liver disease
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Jennifer C Lai, MD, MBA
CONTACT
(415) 476-6422
jennifer.lai@ucsf.edu
Fawzy Barry, BS
CONTACT
(415) 476-6119
fawzy.barry@ucsf.edu

Principal Investigator

Jennifer C Lai, MD, MBA
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
United States
Loma Linda University
Loma Linda, California, 92354
United States
University of California, San Francisco
San Francisco, California, 94143
United States
Northwestern University
Chicago, Illinois, 60611
United States
Indiana University
Indianapolis, Indiana, 46202
United States
Johns Hopkins
Baltimore, Maryland, 21287
United States
University of Michigan
Ann Arbor, Michigan, 48109
United States
Columbia University
New York, New York, 10032
United States
Duke University Medical Center
Durham, North Carolina, 27710
United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15237
United States
Baylor Scott & White Health
Dallas, Texas, 75246
United States
University of Washington
Seattle, Washington, 98195
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Jennifer C Lai, MD, MBA, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2011-10-12
Study Completion Date2028-12-31

Study Record Updates

Study Start Date2011-10-12
Study Completion Date2028-12-31

Terms related to this study

Keywords Provided by Researchers

  • Cirrhosis
  • Liver
  • Liver Transplant
  • Frailty
  • end stage

Additional Relevant MeSH Terms

  • End Stage Liver Disease